Welcome to our dedicated page for CALERES SEC filings (Ticker: CAL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Caleres Inc. filings document the footwear company’s operating results, governance matters, executive-officer changes and capital-structure disclosures. Its Form 8-K reports include quarterly results furnished under Item 2.02 and leadership disclosures under Item 5.02, including principal financial and accounting officer appointments and departures.
Proxy materials cover annual meeting governance topics, board matters and executive compensation disclosures for the company. Filing records also identify Caleres common stock, par value $0.01 per share, listed on the New York Stock Exchange under the symbol CAL, along with material-event, material-agreement and capital-structure reporting relevant to the company’s public-company status.
Caleres, Inc. reported governance updates from its May 28, 2026 Annual Meeting of Shareholders. The board amended the company’s bylaws to reduce the number of directors from eleven to ten, effective May 28, 2026.
Shareholders voted on four proposals, including the election of ten directors. Each nominee, such as Brenda C. Freeman with 23,913,899 votes "For" and 244,396 "Withheld" plus 2,410,093 broker non-votes, received substantially more votes "For" than "Withheld." Other proposals also received significantly more votes "For" than "Against."
Caleres, Inc. has appointed Daniel L. (Dan) Karpel as senior vice president and chief financial officer, effective immediately, making him the company’s principal financial and accounting officer. He previously served as interim CFO and has about 30 years of finance and accounting experience, including prior roles at Caleres.
As CFO, Karpel will receive a $550,000 annual base salary, a target annual cash incentive equal to 65% of salary, a $100,000 payment for interim CFO service, a restricted stock award valued at $350,000, a performance stock award for 2026–2028 with a target value of $550,000, and eligibility for a one-time stock price incentive award with a target value of $385,000.
Caleres also provided first-quarter 2026 outlook, planning to report total sales of $667 million, GAAP diluted earnings per share between $0.39 and $0.41, and adjusted diluted earnings per share between $0.35 and $0.37, and noted it expects EPS above previous guidance.
LANGENSTEIN MOLLY reported acquisition or exercise transactions in this Form 4 filing.
CALERES INC director Molly Langenstein received a stock grant rather than cash for board fees. She was awarded 1,889 shares of Common Stock at a reference price of $13.23 per share as compensation for services as a member of the Board of Directors. After this grant, she directly holds 23,110 shares.
KLEIN WARD M reported acquisition or exercise transactions in this Form 4 filing.
CALERES INC director Ward M. Klein received a stock grant of 1,889 shares of Common Stock as board compensation. The shares were valued at $13.23 per share for this award and were granted in lieu of a quarterly cash payment for his services on the Board of Directors. Following this grant, he directly owns 105,248 shares of Caleres common stock.
Caleres Inc Schedule 13G: Vanguard Capital Management reports beneficial ownership of 1,700,638 shares of Caleres Common Stock as of 03/31/2026, representing 5.01% of the class. The filing shows sole dispositive power over 1,700,638 shares and sole voting power for 228,099 shares.
The filing states these holdings reflect securities managed by Vanguard Capital Management LLC and certain affiliates, including securities held by Vanguard funds and client accounts. The signature block is dated 04/29/2026.
Caleres’ 2026 proxy outlines a challenging 2025 and key shareholder votes. Fiscal 2025 results were pressured by tariffs and a volatile retail environment, though the Brand Portfolio segment grew sales 7.3%, gained women’s fashion footwear share, and expanded owned e‑commerce 17% and international sales 41%.
Famous Footwear generated $1.5 billion in revenue, down 3.6% with comparable store sales down 2.3%, but gained U.S. shoe chain market share. Adjusted operating earnings were $55 million for Brand Portfolio and $47.5 million for Famous. Caleres maintained balance sheet flexibility and returned $9.4 million via dividends. 2025 net sales were $2.757 billion, with adjusted gross margin of 43.5% and adjusted diluted EPS of $0.61.
Shareholders are asked to elect ten directors for one‑year terms, ratify Ernst & Young LLP as auditor, approve a 2026 Incentive and Stock Compensation Plan, and cast an advisory vote on executive pay. The company highlights a declassified, majority‑independent board, strong diversity, and pay programs emphasizing at‑risk, performance‑based compensation with clawbacks and anti‑hedging policies.
Caleres, Inc. files its annual report describing a global footwear business split into Famous Footwear and Brand Portfolio segments. Famous Footwear operated 821 stores at the end of 2025, while Brand Portfolio ran 188 branded stores plus extensive wholesale and e-commerce operations.
Women’s footwear generated 61% of 2025 net sales, with men’s at 21%, children’s at 12% and clothing and accessories at 6%. The company sourced $451.0 million of product in 2025, mainly from Vietnam and China, and had a Brand Portfolio wholesale backlog of $332.2 million at January 31, 2026.
Caleres reports approximately 10,000 employees and emphasizes omnichannel retail, owned and licensed brands such as Sam Edelman, Vionic, Naturalizer, Allen Edmonds and Stuart Weitzman, and data-driven marketing. Key risks include tariffs and trade policy shifts, macroeconomic pressure on discretionary spending, intense competition, supply chain disruption, technology and cybersecurity exposure, ESG and regulatory compliance, and reliance on major suppliers and customers.
Calandra (CAL) reported proposed and completed affiliate sales via Form 144. The filing lists two completed sales: 6,809 shares sold on 03/27/2026 for $71,789.57 and 4,300 shares sold on 03/23/2026 for $49,999.00. The filing also lists restricted stock vesting events under a registered plan dated 01/30/2026 (7,698 shares) and 09/12/2025 (4,335 shares).